ArticleGynecologic oncology reports2017
Prolonged survival after intraperitoneal interleukin-2 immunotherapy for recurrent ovarian cancer.
David R Minor et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this paperpooled itcites it